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Receptor signaling: Dimerization and beyond 
Jeff Stock 
It is has been proposed that hormone receptors which
have only a single transmembrane sequence mediate
signaling via hormone-induced monomer-to-dimer
transitions. But recent studies of analogous receptors
in bacteria indicate that dimerization may be only a
prerequisite for signaling.
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Extracellular signaling molecules, such as insulin, growth
factors and cytokines, effect responses by binding to recep-
tors at the surfaces of target cells. The genes for hundreds
of different receptors have now been sequenced. Although
it is clear that numerous unrelated families of proteins are
involved, they generally share a common dumbbell-like
topology: an extracellular hormone-binding ‘sensory’
domain is connected via an a-helical transmembrane
sequence of about 20 amino acids to one or more cytoplas-
mic signaling domains. Such receptors also seem to share a
common mechanism of transmembrane signaling, whereby
the binding of a ligand to the sensory domain causes inact-
ive monomers to form active dimers (Fig. 1). 
The evidence for a common dimerization mechanism
comes from two basic types of observation [1]. First, it has
been demonstrated in several instances that stimulatory
ligands cause receptor dimerization; and second, dimeriza-
tion that is artificially induced, for instance by antibodies or
by genetically engineered dimerization domains, frequently
causes signaling in the complete absence of stimulatory
ligands. This would seem to be an open and shut case, but
there are a few caveats. One criticism is that the assays used
to measure receptor function have often been performed
with whole cells, in which the receptors are subject to
complex and largely undefined perturbations generated by
the signal transduction systems with which they interact.
Another problem with the dimerization model is much
more specific: the most intensively investigated of all
eukaryotic receptors of this type, the insulin receptor,
clearly cannot function through a monomer-to-dimer shift
as it is permanently locked in a stable dimeric state by inter-
subunit disulfide cross-bridges.
Over the past few years the family of receptors that
mediate chemotaxis responses in Escherichia coli and other
motile bacteria have begun to emerge as a paradigm for
understanding molecular mechanisms of transmembrane
signaling [2]. These proteins have the same basic topology
as eukaryotic single-transmembrane receptors, with an
extracytoplasmic sensory domain connected via an a-
helical transmembrane sequence to an intracytoplasmic sig-
naling domain. The best-defined example is the aspartate
receptor, Tar.
The sensory domain of Tar has been expressed as a soluble
independently folded fragment, and its structure has been
determined by X-ray crystallography in the absence or pres-
ence of aspartate [3]. Within the crystals, the Tar sensory
domain forms a symmetric homodimer with two nonover-
lapping aspartate-binding sites at the monomer–monomer
interface. Binding of aspartate to one site causes an asym-
metric conformational change that occludes the second site.
These observations have been confirmed by studies of the
sensory domain in solution, in which it has been shown that
there is an equilibrium between monomeric and dimeric
forms, that aspartate binding stabilizes the dimer, and that
aspartate binding is negatively cooperative [4]. Similar
results have also been obtained with intact aspartate recep-
tors within the bacterial membrane [4,5]. Thus, as in the
case of many eukaryotic hormone receptors, the binding of
stimulatory ligands to the bacterial chemotaxis receptors
promotes receptor dimerization. In the case of the human
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growth hormone receptor, the X-ray crystal structure of the
sensory domain with bound growth hormone indicates an
asymmetric signaling domain dimer with a single molecule
of bound hormone that bridges two subunits [6].
Recent results with the signaling domain of Tar indicate
that dimerization is crucial to the function of this portion of
the receptor as well. As is commonly the case with single
transmembrane receptors, signaling involves formation of a
relatively stable complex between the receptor and a set of
soluble cytoplasmic signal transduction components [7].
Two cytosolic proteins form a stable complex with Tar.
One, CheA, is a protein kinase; the other, CheW, is an
18 kDa monomeric protein that functions to bind both the
protein kinase and the receptor, thereby mediating forma-
tion of receptor–kinase complexes. Studies of the purified
kinase have established that the protein can exist as either
a monomer or a dimer, and that dimerization is required for
kinase activity [8]. Moreover, formation of active kinase-
receptor complexes seems to require dimerization of the
receptor’s signaling domain [9]. Soluble signaling domain
fragments of Tar are predominantly monomeric, and
although they still bind CheW, they are unable to form
active complexes with the kinase CheA. On the other
hand, genetically engineered hybrids, in which the signal-
ing domain is fused to a ‘leucine zipper’ coiled-coil dimer-
ization domain derived from a eukaryotic transcription
factor, are able to form active kinase complexes [9,10].
Analogous results have been obtained with the signaling
domains of eukaryotic receptors [1].
Considerable effort has been put into understanding how
ligand-induced conformational changes of the sensory
domain that can be seen in crystals could in vivo generate a
signal that propagates to the signaling domain at the other
side of the plasma membrane. A careful analysis indicates
movements that are both parallel and perpendicular to the
plane of the membrane. There is a slight parallel swinging
motion and an approximately 0.1 nm ‘piston’ motion of the
transmembrane helix that connects the sensing and signal-
ing domains of one subunit of a Tar dimer with respect to
the corresponding transmembrane helix in the second
subunit [11]. (Unlike most ‘single transmembrane’ recep-
tors, chemotaxis receptors such as Tar have a second trans-
membrane helix at their amino terminus which is
essentially an uncleaved signal sequence. These amino-
terminal helices do not appear to participate in the aspart-
ate-induced conformational transition that has been
observed in Tar.) The ‘swinging piston’ changes that have
been detected in the connecting helices are so small,
however, that the possibility has been seriously enter-
tained that the domain is for some reason locked in essen-
tially its active conformational state, both in the presence
and the absence of aspartate [12]. Of course, in terms of the
monomer–dimer model, this is certainly the case, as within
the crystals the signaling domain is dimeric whether or not
ligand is bound.
Data from the construction of chimeric receptors support
the notion that general structural changes — such as a
monomer-to-dimer transition — are responsible for trans-
membrane signaling, rather than specific aspartate-
induced conformational changes within the receptor’s
sensory domain. Fusion of the aspartate-binding and
membrane-spanning domains of Tar to the signaling
domain of a distantly related bacterial receptor, EnvZ,
which controls gene expression in response to changes in
extracellular osmotic strength, yields a chimeric receptor
that controls the expression of genes that are normally
EnvZ-responsive, but in response to aspartate rather than
to changes in osmolarity [13]. Moreover, a chimera
between the Tar receptor’s sensing domain and the
insulin receptor’s signaling domain shows insulin-like
tyrosine kinase activity in response to aspartate [14]. The
fusion points in these chimeras were chosen to coincide
with convenient endonuclease restriction sites, with little
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formation of large assemblies with associated
cytoplasmic signal transduction components.
For instance, the bacterial chemotaxis
receptor Tar forms complexes with two other
components, a protein kinase CheA, and an
auxiliary signaling protein, CheW. More than
two-thirds of the protein mass within this
complex lies in the cytoplasm.
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consideration of the structural requirements for propaga-
tion of a transmembrane signal. The results suggest,
therefore, that the transmembrane signaling mechanism is
too robust to depend on the kind of specific conforma-
tional changes advanced in the ‘swinging piston’ type of
mechanism that has been postulated from X-ray crystallo-
graphic observations.
One can make a strong case that Tar uses essentially the
same mechanism for transmembrane signaling as do single
transmembrane hormone receptors in vertebrate cells, and
that this mechanism requires dimerization. There is,
however, compelling evidence that dimerization is not
sufficient for Tar signaling. Despite the fact that aspartate
binds at the subunit interface of sensory domain dimers
[3], and that the protein kinase CheA is active only as a
dimer [8], it is well established that aspartate binding inac-
tivates the kinase — just the opposite of what would be
expected from a monomer–dimer mechanism [15]. It has
also been established that if Tar is locked in a dimeric
state by disulfide cross-linking, it is still capable of trans-
membrane signaling [16]. Finally, studies of Tar–CheA
kinase complexes in vitro indicate that they are relatively
long-lived structures whose stability is unaffected by stim-
ulatory ligands [7]. How can this seeming irrefutable evid-
ence against a stimulus-induced dimerization model for
transmembrane signaling be squared with the extensive
evidence in favor of such a mechanism? The simple solut-
ion to this apparent dilemma is that although dimerization
may be essential for transmembrane signaling, it is not
sufficient: once receptor dimers have formed, other
processes may be required.
If dimerization is not the whole story, what else is involved?
Transmembrane signaling could be mediated by allosteric
transitions between active and inactive dimer conforma-
tions. This type of mechanism would presumably involve
swinging piston motions as have been hypothesized to
occur within Tar dimers [11]. In their original formulation
of the two-state symmetry-conservation mechanism for
allosteric regulation, Monod, Wyman, and Changeux [17]
argued that there was considerable selection for the mainte-
nance of symmetry in protein multimers because asymmet-
ric oligomers would be subject to unlimited polymerization,
as occurs with cytoskeletal proteins such as actin, myosin,
and tubulin. In contrast to the mechanism of regulation of
allosteric enzymes, however, transmembrane signaling
through single-transmembrane receptors such as Tar seems
to involve a disruption of symmetry.
Transmembrane receptors could involve the conversion of
dimers to higher-order oligomers. The formation of
complex receptor arrays or patches has often been associ-
ated with the function of single transmembrane hormone
receptors. In the case of Tar, immunolocalization studies
indicate that receptor–kinase complexes coalesce to form
patches in the membrane at the poles of E. coli cells [18].
These higher-order structures are thought to be compl-
exes made from receptors and associated cytosolic signal-
transducing components. Such assemblies would consist
of two-dimensional signaling networks just below the
surface of the membrane, which would be subject to pert-
urbations induced within an opposing array of sensory
elements at the cell surface (Fig. 2). Thus, dimerization
would be an essential prerequisite for the assembly of
higher-order signaling complexes that function by alterna-
tive mechanisms to mediate signal transduction across the
cell membrane.
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